Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RISCOP-Cognitive profile in a Portuguese cohort of radiological isolated syndrome patients: A case-control study.
Carvalho V, Soares C, Gomes I, Carvalho A, Serrazina F, Rodrigues SG, Pinheiro J, Marques IB, Correia F, Correia AS, de Sá J, Sousa L, Vale J, Sá MJ, Sousa C, Ferreira J. Carvalho V, et al. Among authors: ferreira j. Mult Scler Relat Disord. 2021 May;50:102832. doi: 10.1016/j.msard.2021.102832. Epub 2021 Feb 10. Mult Scler Relat Disord. 2021. PMID: 33596492
REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Batista S, Nunes CC, Cerqueira JJ, Martins Silva A, Correia de Sá J, Ferreira J, Mendonça MT, Pinheiro J, Salgado V, Correia AS, Sequeira J, Costa A, Sousa L. Batista S, et al. Among authors: ferreira j. Neurol Sci. 2021 May;42(5):1995-2003. doi: 10.1007/s10072-020-04726-6. Epub 2020 Sep 30. Neurol Sci. 2021. PMID: 32997282 Free PMC article.
Correction to: REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal.
Batista S, Nunes CC, Cerqueira JJ, Silva AM, de Sá JC, Ferreira J, Mendonça MT, Pinheiro J, Salgado V, Correia AS, Sequeira J, Costa A, Sousa L. Batista S, et al. Among authors: ferreira j. Neurol Sci. 2021 Feb;42(2):767. doi: 10.1007/s10072-020-04879-4. Neurol Sci. 2021. PMID: 33165747 Free PMC article. No abstract available.
Neuromyelitis optica spectrum disorders: A nationwide Portuguese clinical epidemiological study.
Santos E, Rocha AL, Oliveira V, Ferro D, Samões R, Sousa AP, Figueiroa S, Mendonça T, Abreu P, Guimarães J, Sousa R, Melo C, Correia I, Durães J, Sousa L, Ferreira J, de Sá J, Sousa F, Sequeira M, Correia AS, André AL, Basílio C, Arenga M, Mendes I, Marques IB, Perdigão S, Felgueiras H, Alves I, Correia F, Barroso C, Morganho A, Carmona C, Palavra F, Santos M, Salgado V, Palos A, Nzwalo H, Timóteo A, Guerreiro R, Isidoro L, Boleixa D, Carneiro P, Neves E, Silva AM, Gonçalves G, Leite MI, Sá MJ. Santos E, et al. Among authors: ferreira j. Mult Scler Relat Disord. 2021 Nov;56:103258. doi: 10.1016/j.msard.2021.103258. Epub 2021 Sep 8. Mult Scler Relat Disord. 2021. PMID: 34583213
Late onset neuromyelitis optica spectrum disorders (LONMOSD) from a nationwide Portuguese study: Anti-AQP4 positive, anti-MOG positive and seronegative subgroups.
Santos E, Moura J, Samões R, Sousa AP, Mendonça T, Abreu P, Guimarães J, Correia I, Durães J, Sousa L, Ferreira J, de Sá J, Sousa F, Sequeira M, Correia AS, André AL, Basílio C, Arenga M, Marques IB, Perdigão S, Alves I, Santos M, Salgado V, Palos A, Guerreiro R, Isidoro L, Boleixa D, Carneiro P, Neves E, Silva AM, Gonçalves G, Sá MJ. Santos E, et al. Among authors: ferreira j. Mult Scler Relat Disord. 2022 Jul;63:103845. doi: 10.1016/j.msard.2022.103845. Epub 2022 May 4. Mult Scler Relat Disord. 2022. PMID: 35594635
[No title available]
[No authors listed] [No authors listed] PMID: 37036904
Safety and Effectiveness of Cladribine in Multiple Sclerosis: Real-World Clinical Experience From 5 Tertiary Hospitals in Portugal.
Santos M, Sequeira J, Abreu P, Guerreiro R, Santos M, Ferreira J, Brum M, Ladeira F, Leitão L, Dias R, Sá MJ, Salgado V, Capela C, de Sá J. Santos M, et al. Among authors: ferreira j. Clin Neuropharmacol. 2023 May-Jun 01;46(3):105-111. doi: 10.1097/WNF.0000000000000552. Epub 2023 Apr 11. Clin Neuropharmacol. 2023. PMID: 37191564
4,848 results